Study of Cabozantinib (XL184) Administered Alone or in Combination with Atezolizumab in subjects with Locally advanced or Metastatic Solid Tumors (XL184-021)
Study of Cabozantinib (XL184) Administered Alone or in Combination with Atezolizumab in subjects with Locally advanced or Metastatic Solid Tumors (XL184-021)
Trial Category:
Lung
Phase
I
Contact(s)
Location(s)
Nebraska Cancer Specialists, Omaha, NE
